The Hindu Business Line : SC appoints new technical member for Glivec case - The Diigo Meta page

• 13 Oct 08
  

  gibreel ferishta

  All decks seem to have been finally cleared for the review of the rejection of Novartis’ patent on its cancer drug Glivec. The Supreme Court has appointed Dr P.C. Chakraborty, of the Patent Office in Kolkata, as technical member on the Intellectual Property Appellate Board (IPAB) for the review of this case.

  Glivec patent cancer IP

  • The reason for Novartis’ concern was that the earlier technical member appointed to the IPAB, Mr S. Chandrasekaran, was the former Patent Controller under whom Novartis’ patent on Glivec had been rejected in the first place, in January 2006.

    
    

    The new technical member Dr Chakraborty is Deputy Controller of Patents and Designs at the Kolkata Patent Office, and his name was selected from a list of 20 patent attorneys and 22 patent controllers that the Centre submitted to the apex court, a legal source handling the case told Business Line.

Would you like to comment?

Join Diigo for a free account, or sign in if you are already a member.